The Effect of Directing Ribozymes to Attack Proliferating Cell Nuclear Antigens and Inhibit the Growth of Cancer Cells
CSEF · 2002 Biochemistry/ Molecular Biology
Overview
Objectives/Goals My project was to determine if by specifically directing a ribozyme to attack the Proliferating Cell Nuclear Antigen (PCNA mRNA), will the growth of a cancer cell be inhibited and thus kill the cell; and if the cells died, to determine the origin of their death. Methods/Materials A total of eight rat and human brain cancer cell cultures were treated with either ribozyme, ribozyme and lipid, dysfunctional ribozyme and lipid, c2 cerimide, or nothing. The treatments were cultured and WST-1 dye was added to be metabolized in the cells. The metabolic rate was determined by an ELISA plate reader, which read how much dye was in the cells. A different culture of cells had PI dye and ANNEXIN-5 dye added to the treatments. These were then read by flow cytometry to determine whether the cells died through necrosis or apoptosis. Results When compared to the control cells, the cancer cells which had the ribozymes and a specific lipid added seemed to have a reduction in growth, as much as 24%. However, the cells that had a dysfunctional ribozyme and lipid also had a reduction in growth, up to 18% when compared to the normal cells. In the second assay, when the mode of death was determined, our control worked. The cells with the c2 cerimide, a chemical know to induce apoptosis, did in fact die through apoptosis. The cells that had no treatment were still living, however the cells with all other treatments died through necrosis and not apoptosis. Conclusions/Discussion Although the first assay appeared to have succeeded in reducing the cancer cell count, the treatments that had the largest death rate were due to the toxic lipid that was added to them. Also, the naked ribozyme treatment did reduce the growth of the cancer cells, which means that although the RNA piece is small, it will be taken into the cell. Less exciting was the death of the brain cancer cells, which appeared to be mainly through necrosis. This means the cell lyses or bursts, which can cause severe swelling. However, the control c2 cerimide treatment induced apoptosis assuring me that the procedure I went through was correct and can be repeated in later experiments.
Summary statement
My project involved using a particular known catalyst, called ribozyme, and directing it to attack PCNA, a transcription factor necessary for polymerase to proofread the mRNA, thus creating shorter mRNA fragments and cancer cell death.
Help received
Dr. Joan Robbins and Mr. Eric Alspaugh, Immusol, Inc. for direction and assistance; Dr. Carol Kruse at Univ. of Colorado for consultation.
Awards (1)
- Category Award
Competition history
- CSEF 2002
Resources
Related projects
CSEF · 2011
A Novel Approach to Fighting Cancer: Silencing hif-1 in C. elegans to Study the Resulting Effects of Hypoxic Survival
CSEF · 2018
Identifying the Mechanisms of Liver Cancer Cell Drug Resistance
CSEF · 2016
Arresting Mitotic Division in Allium cepa Cells: A Phase I Cancer Study
CSEF · 2005
In Vitro Evaluation of Cytotoxic and Anti-Angiogenic Cancer Therapies on Human Tumor Cells
CSEF · 2017
Efficacy of BIBR1532 in Combination with Nutrient Deprivation on Reduction of Cell Viability in MCF7 and HT1080
CSEF · 2012
Can It Bee? Investigating Cytotoxicity and Gene Regulation of Potential Anti-Cancer Agent Propolis
ISEF · 2016
Novel Selection of Enzymes Loaded in Mesoporous Nanoparticle Carrier Engineered to Selectively Target Cancer Cells Using Aptamer
CSEF · 2018
Alkaloid Quantification of Catharanthus roseus and Vinca major and Its Effects on Cell Viability
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects